Trends in cervical cancer epidemiology and vaccination coverage in Ukraine
- PMID: 40526650
- DOI: 10.36740/WLek/205358
Trends in cervical cancer epidemiology and vaccination coverage in Ukraine
Abstract
Objective: Aim: To evaluate regional aspects of cervical cancer epidemiology and adherence to vaccination in Ukraine.
Patients and methods: Materials and Methods: The data about cervical cancer age-standardised incidence rate in 2014-2019 in Ukraine was obtained from the archives of National Cancer Registry of Ukraine. The data about vaccination coverage were obtained from the reports by the Centre of Public Health of Ukraine.
Results: Results: The average cervical cancer age-standardised incidence rate in Ukraine in 2014-2019 was 14.9 per 100,000. Zhytomyr, Khmelnytskyi and Kirovohrad oblasts exhibited values 20% above the national level. The general trend of cervical cancer incidence at the national level in 2014-2019 was declining (from 15.0 to 14.1). Kyiv, Mykolaiv, Sumy and Chernihiv oblasts exhibited increasing trends in age-standardised incidence rate (>20%). The average zero-dose children proportion in Ukraine in 2016 -2024 was 30.3%. Vaccination coverage in Ukraine has been improving over the observation period in all oblasts.
Conclusion: Conclusions: Ukraine in 2014-2019 was characterised by the decreasing cervical cancer age-standardised incidence rate. Vaccination coverage in Ukraine in 2016-2024 has been improving, which increases the likelihood of a good response to the planned HPV vaccination campaign. Several regions with deviations from the national levels of cervical cancer incidence and vaccination coverage were identified.
Keywords: Cervical cancer; human papillomavirus; vaccination; prevention; public health.
Similar articles
-
Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study.Lancet Oncol. 2019 Mar;20(3):394-407. doi: 10.1016/S1470-2045(18)30836-2. Epub 2019 Feb 19. Lancet Oncol. 2019. PMID: 30795950
-
Prediction of cervical cancer incidence in England, UK, up to 2040, under four scenarios: a modelling study.Lancet Public Health. 2018 Jan;3(1):e34-e43. doi: 10.1016/S2468-2667(17)30222-0. Epub 2017 Dec 19. Lancet Public Health. 2018. PMID: 29307386 Free PMC article.
-
Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.Vaccine. 2013 Dec 31;31 Suppl 7:H46-58. doi: 10.1016/j.vaccine.2013.06.043. Vaccine. 2013. PMID: 24332297
-
Prophylactic human papillomavirus vaccination and primary prevention of cervical cancer: issues and challenges.Clin Microbiol Infect. 2012 Oct;18 Suppl 5:64-9. doi: 10.1111/j.1469-0691.2012.03946.x. Epub 2012 Aug 6. Clin Microbiol Infect. 2012. PMID: 22862799 Review.
-
Moving forward: human papillomavirus vaccination and the prevention of cervical cancer.J Womens Health (Larchmt). 2007 Nov;16(9):1258-68. doi: 10.1089/jwh.2007.0493. J Womens Health (Larchmt). 2007. PMID: 18001182 Review.